Application 090416
- Type
- ANDA
- Sponsor
- GLENMARK GENERICS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | MOEXIPRIL HYDROCHLORIDE | MOEXIPRIL HYDROCHLORIDE | TABLET;ORAL | 7.5MG | No | No |
| 002 | MOEXIPRIL HYDROCHLORIDE | MOEXIPRIL HYDROCHLORIDE | TABLET;ORAL | 15MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 68462-208 | Moexipril Hydrochloride | Moexipril Hydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-208 | Moexipril Hydrochloride | Moexipril Hydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-209 | Moexipril Hydrochloride | Moexipril Hydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-209 | Moexipril Hydrochloride | Moexipril Hydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |